1. A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV‐infected individuals with occult HBV infection. Issue 1 (1st June 2012) Authors: Cassini, R.; De Mitri, M. S.; Gibellini, D.; Urbinati, L.; Bagaglio, S.; Morsica, G.; Domenicali, M.; Verucchi, G.; Bernardi, M. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 1(2013) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients. (April 2016) Authors: Bagaglio, S.; Uberti-Foppa, C.; Messina, E.; Merli, M.; Hasson, H.; Andolina, A.; Galli, A.; Lazzarin, A.; Morsica, G. Journal: Clinical microbiology and infection Issue: Volume 22:Number 4(2016) Page Start: 386.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of alpha-fetoprotein on survival in HIV-infected patients with hepatocellular carcinoma. (October 2019) Authors: Messina, E.; Galli, L.; Morsica, G.; Hasson, H.; Bagaglio, S.; Salpietro, S.; Bhoori, S.; Mazzaferro, V.; Lazzarin, A.; Castagna, A.; Foppa, C. Uberti Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 3 Page Start: e260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort. (February 2019) Authors: Quaranta, M.G.; Rosato, S.; Ferrigno, L.; Amoruso, D.C.; Monti, M.; Di Stefano, P.; Filomia, R.; Tamburini, F.; Migliorino, G.; Zanetto, A.; Degasperi, E.; Cavalletto, L.; Brancaccio, G.; Blanc, P.; Cannizzaro, M.; Castelli, E.; Morsica, G.; Licata, A.; Kondili, L.A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience. (February 2019) Authors: Di Maio, V.C.; Aragri, M.; Masetti, C.; Paolucci, S.; Bruzzone, B.; Degasperi, E.; Barbaliscia, S.; Pollicino, T.; Minichini, C.; Calvaruso, V.; Rendina, M.; Cento, V.; Teti, E.; Micheli, V.; Ghisetti, V.; Polilli, E.; Palitti, V. Pace; Landonio, S.; Lenci, I.; Donnarumma, L. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Steatosis in patients with HCV chronic liver disease: Baseline results from patients enrolled in the PITER cohort study. (7th October 2015) Authors: Weimer, L.E.; Falzano, L.; Mallano, A.; Quaranta, M.G.; Massella, M.; Rosato, S.; Colombato, P.; Giubilei, L.; Ciancio, A.; Iannone, A.; Filomia, R.; Orlandini, A.; Petta, S.; Tamburrini, F.; Blanc, P.; D'Aversa, F.; Pasetto, M.C.; Erne, E.M.; Ieluzzi, D.; Storato, S. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 3 Page Start: e224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen. (February 2020) Authors: Di Maio, V.C.; Aragri, M.; Masetti, C.; Paolucci, S.; Bruzzone, B.; Degasperi, E.; Barbaliscia, S.; Pollicino, T.; Minichini, C.; Calvaruso, V.; Rendina, M.; Cento, V.; Teti, E.; Micheli, V.; Allice, T.; Polilli, E.; Palitti, V. Pace; Landonio, S.; Lenci, I.; Francioso, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗